Company Profile · Healthcare
SIGA Technologies Inc
SIGA · US
- Country
- USA
- IPO date
- Sep 9, 1997
- Employees
- 49
- Website
- www.siga.com
Buffett Score
60/100
Medium
Financial snapshot
Market cap$242.85M
Revenue (TTM)$53.66M
EBITDA-$10.55M
Profit margin-5.19%
ROE-1.49%
Forward P/E2.94
PEG3.37
EPS-$0.04
Dividend yield0%
52-week range$2.83 – $7.92
Analyst target$17.53
Data from EODHD, shown in the reporting currency; for reference only, not investment advice.
About the company
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.
Background
History
Coming soonThis section is being filled in — check back soon.
Industry position
Coming soonThis section is being filled in — check back soon.
Research on this stock
No reports on this stock in your language yet.